Cargando…

Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is strongly associated with obesity-related ectopic fat accumulation in the liver. Hepatic lipid accumulation encompasses a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huh, Jin Young, Saltiel, Alan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639992/ https://www.ncbi.nlm.nih.gov/pubmed/34848839 http://dx.doi.org/10.1038/s12276-021-00712-w

Ejemplares similares

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes
por: Möser, Christine V., et al.
Publicado: (2015)

TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
por: Louis, Cynthia, et al.
Publicado: (2018)

Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
por: Sousa-Lima, Inês, et al.
Publicado: (2021)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis
por: Pillai, Smitha, et al.
Publicado: (2015)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease
por: Zarfeshani, Aida, et al.
Publicado: (2014)

Human Metapneumovirus Induces IRF1 via TANK-Binding Kinase 1 and Type I IFN
por: Loevenich, Simon, et al.
Publicado: (2021)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

The Scaffold Protein TANK/I-TRAF Inhibits NF-κB Activation by Recruiting Polo-like Kinase 1
por: Zhang, Wanqiao, et al.
Publicado: (2010)

Commentary: Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity
por: Freischmidt, Axel, et al.
Publicado: (2020)

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
por: Ishikawa, Hideki, et al.
Publicado: (2022)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Publicado: (2023)

Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice
por: Perfield, James W., et al.
Publicado: (2013)

The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
por: Chambel, Sílvia S., et al.
Publicado: (2015)

Comparative In Silico Analysis and Functional Characterization of TANK-Binding Kinase 1–Binding Protein 1
por: Sawal, Humaira Aziz, et al.
Publicado: (2023)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
por: Chae, Woori, et al.
Publicado: (2022)

Profile analysis and functional modeling identify circular RNAs in nonalcoholic fatty liver disease as regulators of hepatic lipid metabolism
por: Xie, Yang, et al.
Publicado: (2022)

PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
por: Rana, Rajashree, et al.
Publicado: (2019)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection
por: Perry, Andrea K., et al.
Publicado: (2004)

Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease
por: Min, Robert W. M., et al.
Publicado: (2022)

Cyclic stretch regulates immune responses via tank‐binding kinase 1 expression in macrophages
por: Nakagawa, Anna, et al.
Publicado: (2022)

Modelling of C-terminal tail of human STING and its interaction with tank-binding kinase 1
por: ATA OUDA AL-MASRI, Rahaf, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2020)

Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease
por: Pan, Xiongfeng, et al.
Publicado: (2021)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021)

Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease
por: Liu, Jifeng, et al.
Publicado: (2023)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

Deconstructing IκB kinase
por: Van Epps, Heather L.
Publicado: (2005)

Disulfide-Mediated Stabilization of the IκB Kinase Binding Domain of NF-κB Essential Modulator (NEMO)
por: Zhou, Li, et al.
Publicado: (2014)

Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury
por: Zhong, Xiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b5gsuh2sj4ubmquefj4hc24ibo